|
|
|
|
Vol. 55, Issue 1, 102-108, January 1999
Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts
| |
Summary |
|---|
|
|
|---|
Ethanol enhances the gating of a family of related ligand-gated
ion channels including nicotinic acetylcholine, serotonin type 3,
-aminobutyric acid-A, and glycine receptors. This common action may reflect shared molecular and kinetic mechanisms. In all of
these receptors, ethanol enhances multichannel currents elicited with
low agonist concentrations, but not with high agonist concentrations. A
single mutation in the nicotinic receptor
subunit,
T263I, causes
ethanol to enhance multichannel currents elicited with both low and
high acetylcholine concentrations. Based on the ratios of acetylcholine
EC50s in the presence and absence of ethanol, this
mutant's sensitivity to enhancement is similar to wild type. Ethanol
enhancement of
T263I receptor activation shows no voltage
dependence. In the presence of ethanol, the apparent single-channel
conductance of the
T263I receptor is reduced and the apparent
channel lifetime is lengthened. Both the 28% increase in maximal
current and the 2-fold reduction in EC50 observed at 300 mM
ethanol are quantitatively predicted by simulation of a simple kinetic
scheme in which ethanol increases by 4-fold the ratio of microscopic
opening rate (
) to closing rate (
) for acetylcholine-bound
T263I receptors. We conclude that ethanol enhancement of
T263I
currents reflects stabilization of its open-channel state relative to
agonist-bound closed states. Ethanol effects in wild-type receptors can
also be explained by this mechanism.
| |
Introduction |
|---|
|
|
|---|
Agonist-induced
activation of both peripheral and neuronal nicotinic acetylcholine
receptors (nAChRs) is enhanced by ethanol (EtOH). (Gage, 1965
; Bradley
et al., 1980
; Forman et al., 1989
; Nagata et al., 1996
). Similar EtOH
enhancement is observed in related ligand-gated channels such as
-aminobutyric acid-A, 5-hydroxytryptamine-3, and glycine
receptors and it is thought that enhancement of the function of these
receptors plays a role in EtOH's behavioral effects (Leidenheimer and
Harris, 1992
; Aguayo and Pancetti, 1994
; Machu and Harris, 1994
;
Deitrich et al., 1997
). The kinetic mechanism underlying activation
enhancement by ETOH is uncertain.
In peripheral nAChRs from Torpedo electroplaque and muscle,
EtOH enhancement of ACh-gated currents is observed with low
concentrations of ACh, but currents elicited by saturating ACh
concentrations are unaffected by up to 300 mM EtOH (Forman et al.,
1989
; Wu et al., 1994
). Thus, ACh-response relationships are shifted
toward lower concentrations, a phenomenon known as leftward (or
sinistral) shift.
The leftward shift of ACh responses by EtOH could be achieved by
altering several different steps in the gating mechanism of nAChR. The
most obvious possibility is that EtOH might enhance the affinity of
agonist binding sites. Secondly, EtOH might increase the probability of
channel opening (popen) after agonist binding. Increasing popen is predicted to result in
leftward shift of ACh responses, but because nAChRs with both agonist
sites occupied by ACh are estimated to be open more than 97% of the
time, increasing popen will not dramatically
increase peak responses at saturating ACh concentrations. Another
possible mechanism, reported for benzodiazepine enhancement of
-aminobutyric acid-A receptors, is that nAChR single-channel
conductance could be increased by EtOH, although this mechanism should
also increase peak current responses at high ACh (Eghball et al.,
1997
). Furthermore, in experiments where desensitization or agonist
channel block moderates the overall measured response, leftward shifts
in agonist responses could occur if EtOH reduces these actions.
Nicotinic receptors formed from wild-type
,
, and
subunits
and
subunits containing a channel mutation,
T263I, are affected by EtOH in a manner that has not been previously reported. ACh-induced currents from
T263I receptors are enhanced by EtOH at both low and
high ACh concentrations. A detailed examination of EtOH effects on
T263I mutant receptors supports a model where enhanced activation in
the presence of EtOH is due to an increased opening probability of
ACh-bound nAChRs.
| |
Materials and Methods |
|---|
|
|
|---|
Materials.
cDNAs encoding wild-type
,
,
, and
subunits and the
Y198F mutant in pSP64T vectors were provided by Dr.
James McLaughlin (Tufts Medical School, Boston, MA) and
T263I mutant
cDNA in pGEM2-SP6 was provided by Dr. Cesar Labarca (California
Institute of Technology, Pasadena, CA). Acetylcholine chloride (ACh),
EtOH, and other chemicals were purchased from Sigma Chemical Co. (St.
Louis, MO).
Xenopus Oocyte Expression.
Wild-type and
mutant nAChRs were expressed on the surface of Xenopus
oocytes after injection of oocytes with messenger RNA mixtures encoding
the four nAChR subunits. Detailed methods were previously described
(Forman et al., 1995
). All procedures with frogs were approved by the
Massachusetts General Hospital Animal Care Committee. After
microinjection, oocytes were incubated for 48 to 96 h, then
manually stripped of their vitelline membranes and used for electrophysiology.
Rapid Perfusion Patch-Clamp Electrophysiology.
Electrophysiology recordings were made at room temperature
(20-22°C). Borosilicate patch pipettes were polished to give open tip resistance of 2-5 M
. For rapid perfusion studies, oocyte membrane patches were pulled in the outside-out configuration and held
at
50 mV. Inside and outside buffers were symmetrical K-100 (97 KCl
mM, 1 MgCl2 mM, 0.2 EGTA mM, and 5 K-HEPES mM, pH 7.5).
Currents through the patch-clamp amplifier (Axopatch-200A; Axon
Instruments, Foster City, CA) were filtered (8-pole bessel, 2 kHz) and
digitized at 5 to 10 kHz using a 586-class PC, a 12-bit A/D converter
(National Instruments, Austin, TX), and custom software.
Single-Channel Studies.
Recordings were made at room
temperature using excised inside-out patches held at 150 mV. Pipettes
were 2 to 5 M
resistance and uncoated. Pipette and bath solutions
were symmetrical K-100 and ACh in the pipette was 0.2 to 1.0 µM.
EtOH, when present, was added to the pipette solution only. Continuous
recordings were acquired at 10 kHz digitization with 5 kHz filtering
using the FETCHEX program in pClamp6.0 (Axon Instruments).
Data Analysis. In rapid concentration-jump studies, each patch studied under a given set of ACh/EtOH conditions was exposed to these drugs sequentially 8 to 16 times with a recovery period in between each exposure. The ensemble of current traces were averaged. Control ensemble average currents (saturating ACh without EtOH) were assessed before and after experiments where patches were exposed to EtOH. Data was not analyzed if the two control peak currents differed by more than 10%. Experimental peak currents were normalized to the average peak from the two bracketing control measurements in the same patch. For concentration-response studies, normalized data from at least three patches from different oocytes were pooled and averaged for each EtOH concentration studied.
Exponential functions (eq. 1) were fitted to the decay portion of current data.
|
(1) |
|
(2) |
Kinetic Simulations. MATLAB software (The Mathworks, Natick, MA) was used to both generate simulated nAChR currents by the Q-matrix method and to identify peak current amplitudes in the simulations.
| |
Results |
|---|
|
|
|---|
EtOH enhances
T263I currents at high ACh.
Oocyte membrane
patches expressing nicotinic receptors containing the
T263I mutation
produced ACh-induced currents very similar to those of wild-type
receptors. Upon exposure to submillisecond ACh concentration jumps,
multichannel inward currents rapidly peaked and then desensitized
monoexponentially (Fig. 1A, 1 mM ACh
trace). As previously reported,
T263I mutant nAChRs are
characterized by an ACh EC50 that is about 3-fold higher
than that for wild type (56 ± 2 µM; Fig.
2), and maximal ACh-induced
desensitization proceeds at a rate similar to that for wild-type
receptors (Forman, 1997
).
|
|
T263I receptor currents were elicited with high
ACh concentrations in the presence of EtOH, we unexpectedly observed
currents that were higher than those elicited by ACh alone (Fig. 1A).
In a series of five patches, currents elicited with 1 mM ACh were
enhanced up to 29% in the presence of high EtOH concentrations (Fig.
1B). We also observed significant EtOH-dependent enhancement of
currents at low EtOH concentrations associated with inebriation. At 50 mM EtOH, ACh-induced currents were enhanced 11 ± 3%. A logistic
fit to the EtOH-dependent enhancement data gave half-maximal
enhancement at 80 ± 21 mM. EtOH also increased the apparent
ACh-induced desensitization rate by nearly 50% (Fig. 1A).
EtOH Shifts
T263I ACh Response Leftward.
The enhancing
action of EtOH was quantified by determining the extent of EtOH-induced
leftward shift in agonist response curves. In wild-type
Torpedo and mouse nAChRs, 300 mM EtOH causes the ACh
EC50 to decrease about 2-fold (Forman et al., 1989
; Zhou
and Forman, submitted for publication.). We therefore measured ACh concentration responses in patches expressing
T263I nAChRs both in
the absence and presence of 300 mM EtOH.
1 mM). The fitted EC50 for ACh
in the presence of 300 mM EtOH was 29 ± 3.1 µM, approximately
half of its value in the absence of EtOH. Thus, the magnitude of
EtOH-induced leftward shift in
T263I nAChR responses is the same as
that observed in both wild-type mouse and Torpedo nAChRs.
EtOH Enhancement Shows No Voltage Dependence.
ACh can act as a
voltage-sensitive channel blocker (self-inhibition) as well as an
agonist. In wild-type nAChRs, channel block is observed at ACh
concentrations above 1 mM and at membrane potentials below
50 mV
(Sine and Steinbach, 1984
). If ACh is a potent blocker of
T263I
nAChRs, a possible mechanism to explain EtOH enhancement at high ACh is
that EtOH weakens channel block by ACh (or other ions). We tested this
hypothesis by determining whether EtOH enhancement of both wild-type
and
T263I mutant channels was dependent on the membrane holding potential.
|
T263I mutant nAChRs, inward rectification of macroscopic currents
was much stronger than that seen in wild type, and again the null
potential was near 0 mV (Fig. 3B). I-V relationships were linear at
negative voltages, demonstrating that ACh block of
T263I nAChRs
remains weak in the presence of the pore mutation. EtOH enhancement of
T263I multichannel currents was of equal magnitude at both negative
and positive holding potentials. In the data shown in Fig. 3B, 300 mM
EtOH enhanced inward multichannel currents by 42% and outward currents
by 40%.
EtOH Reduces Single-Channel Conductance of
T263I nAChRs.
We
examined whether enhancement of
T263I multichannel currents was
reflected in single-channel conductances by measuring single-channel
conductances in excised inside-out patches using a low concentration of
ACh (0.5 µM) in the pipette.
T263I-channel openings were very brief and appeared to be of
varying magnitude (Fig. 4, top left).
Amplitude histograms from
T263I currents showed a baseline peak and
a single opening peak with an average conductance (±S.E.M.,
n = 4) of 47 ± 1.0 pS (Fig. 4, top middle). In
the presence of EtOH, single-channel openings appeared to have longer
durations and were of more consistent amplitude (Fig. 4, bottom left).
EtOH decreased the apparent single-channel conductance of
T263I nAChRs by 19 ± 1.0% (±S.E.M., n = 4)
to 38 ± 1.6 pS (Fig. 4, bottom middle).
|
EtOH Increases Apparent Single-Channel Lifetime of
T263I
nAChRs.
In recordings where over 95% of opening events were
single openings, open-time duration histograms revealed two distinct
T263I channel open lifetimes. Most openings had fitted mean
lifetimes below 0.2 ms. (Fig. 4, top right, see legend for details). In the presence of 400 mM EtOH, both short and long opening times increased and there was a shift in the distribution toward more long
openings (Fig. 4, bottom right). These EtOH effects on channel lifetimes were consistently observed in a total of eight patches.
| |
Discussion |
|---|
|
|
|---|
The major finding of this study is that EtOH enhances macroscopic
currents from
T263I mutant nAChRs at both low and high ACh
concentrations. This result is in contrast to EtOH actions on wild-type
nAChRs, where current enhancement is seen with low ACh, but only weak
inhibition is apparent with high ACh concentrations. We investigated
the
T263I mutant's interactions with EtOH in detail to determine
why EtOH affects it differently from wild-type nAChRs. Our analysis
demonstrates that EtOH enhancement of nAChR function is due to an
increase in the opening probability of agonist-bound receptors.
A number of different EtOH-associated changes in the nAChR gating
mechanism could lead to enhancement of multichannel currents under
different agonist conditions. A reaction scheme that incorporates the
steps leading to channel opening, blocking, and desensitization is
shown in Fig. 5. For simplicity, the two
ACh binding sites are shown with equal microscopic affinities, because
the arguments that follow would be equally valid for a model with
distinct binding affinities. In wild-type mouse muscle nAChRs,
microscopic rates for ACh binding to agonist sites
(kon) are diffusion limited, near
108 M
1
s
1, whereas the rate for dissociation of ACh
(koff) is estimated to be >6000
s
1 (Lingle et al., 1992
; Zhang et al., 1995
).
After binding of two ligands, opening (
) occurs at rates up to
60,000 s
1 (Zhang et al., 1995
; Maconochie and
Steinbach, 1998
) and closing (
) at about 100 to 300 s
1 (Dilger et al., 1991
; Zhang et al., 1995
).
At 21°C and
50 mV, the ACh open-channel blocking rate is about
5 × 106
M
1
s
1 and the unblocking rate is about 3000 s
1 (Sine and Steinbach, 1984
). Agonist binding
and channel opening and blocking are all very fast compared with
desensitization (kd
10 s
1), so that peak current after submillisecond
concentration jumps should reflect only these steps. At saturating (but
not blocking) ACh concentrations, all receptors rapidly enter the
A2R state and the resulting maximal macroscopic
current will be the unit current, i, times the number of
channels times the open probability of doubly ACh-bound receptors
popen =
/(
+
). Channel block by EtOH will
also affect maximal currents by reducing the effective channel
conductance.
|
Enhancement of multichannel nAChR currents could be associated
with changes in agonist binding, single-channel opening probability, channel conductance, channel block, or desensitization kinetics. Our
data directly rule out some of these possibilities. The use of rapid
concentration jumps at excised membrane patches enables direct
observation of enhancement in multichannel peak currents, which is
clearly independent of desensitization (Fig. 1). With longer agonist
applications, we can directly observe EtOH effects on the
desensitization rate, kd. Consistent with
previous observations in studies of Torpedo nAChR (Forman et
al., 1989
; Wu and Miller, 1994
), we find that EtOH accelerates nAChR
desensitization in the presence of both low and high ACh
concentrations. In slower current assays, this effect should reduce,
not enhance, measured peak currents.
We also show that voltage-dependent agonist blockade of nAChR channels
is negligible under the experimental conditions used for this study.
I-V relationships for both wild-type and mutant nAChRs show inward
rectification due to voltage-dependent channel closing rate (Auerbach
et al., 1996
), but enhancement of
T263I currents by EtOH is equal at
both positive and negative holding potentials (Fig. 3). In addition,
our single-channel studies demonstrate that EtOH does not enhance
single-channel nAChR conductance (Fig. 4), ruling this out as a
possible mechanism.
The EtOH-induced leftward shift in agonist concentration responses
could be caused by either enhanced agonist binding or by enhanced
popen. Because the popen of
ACh-bound wild-type nAChR is near 1.0, either of these actions would
lead to an unchanged maximal current at saturating ACh. Partial
agonists such as suberyldicholine, decamethonium, or nicotine bind to
the ACh agonist sites on nAChR, but the probability of channel opening
when these sites are occupied is low. EtOH and other short-chain
alcohols enhance nAChR function at both low and high partial agonist
occupancy (Wu and Miller, 1994
; Tonner et al., 1992
; Liu et al., 1994
).
These observations suggest that EtOH affects the probability of channel
opening after ligands bind, but do not rule out a mechanism where EtOH
affects affinity for the agonist site.
A critical problem with the partial agonists is that they are all
potent channel blockers, and the overall maximal current observed with
these agonists is a function of both channel opening and blockade.
Enhancing ligand binding affinity at the agonist sites without
affecting popen or agonist channel blocking
affinity of these compounds would increase maximal current (Tonner et
al., 1992
; Liu et al., 1994
). In the absence of agonist channel block, as established for our results using ACh as the agonist, simply enhancing ligand binding affinity would result in a leftward shift in
the concentration-response curve without changing maximal current. Because EtOH does not enhance single-channel conductance and the number
of receptors in an excised patch is unlikely to change (especially on
the rapid time scale of our agonist concentration jumps), the only
mechanism that can account for the EtOH-induced increase in maximal
T263I multichannel currents is an increase in single-channel
popen.
To test whether we could quantitatively account for both the increased
maximal current and the decreased EC50 observed
in the presence of 300 mM EtOH, we simulated
T263I nAChR currents based on a modified scheme (Fig. 5) without agonist block (Fig. 6). Kinetic parameters for the simulation
were those given above for wild-type receptors, except that we set the
channel closing rate,
= 8000 s
1 based on
our open lifetime estimates (Fig. 4). We varied
and found that at
= 20,000 s
1 (
/
= 2.5; Fig. 6
),
that the EC50 of the simulated
concentration-response data was 53 µM, close to the actual value for
T263I receptors (Fig. 2). The maximal popen in
this simulation was 0.71. To simulate the effect of EtOH, we increased
the
/
ratio by either increasing
or decreasing
(with
similar results). At
/
= 10 (Fig. 6
), the
EC50 of simulated data dropped to 25 µM and the
maximal popen increased to 0.91. Thus, a 4-fold
increase in
/
caused a 2-fold decrease in
EC50 and a 28% increase in maximal
popen. The remarkable correlation between the
simulated data and our measurements in the absence and presence of EtOH
is demonstrated in Fig. 6 (right panel), where simulated
concentration-response curves are plotted with renormalized
electrophysiologic data from Fig. 2.
|
Our results confirm prior studies suggesting that EtOH acts on
ligand-gated ion channels by stabilizing the open-channel state relative to the closed agonist-bound state (Aracava et al., 1991
; Bradley et al., 1994
; Wu and Miller, 1994
; Zhou and Lovinger, 1998
).
Furthermore, our simulation of nAChR kinetics suggests that 300 mM EtOH
increases
/
by about 4-fold. Indeed, the linear log-log
relationship between predicted EC50 and
/
seen in Fig. 6 (left panel) has a slope near
0.5, indicating that
EC50 depends on
(
/
)
1/2. This result is also predicted by
an approximate numeric solution for EC50 based on
Fig. 5 (see Appendix).
A direct implication of our observation that EtOH increases maximal
currents in
T263I receptors is that the microscopic
popen of ACh-bound
T263I receptors must be
significantly less than 1.0. The simulation shown in Fig. 6 suggests
that popen is near 0.7, but we can also estimate
a value directly from our measurements. About 28% enhancement of
maximal multichannel currents (at ACh
1 mM) in patches expressing
T263I receptors was observed at the highest EtOH concentrations we
studied. Thus, assuming popen for ACh-bound
T263I receptors in the presence of 300 to 700 mM EtOH is near 1.0, popen in the absence of EtOH can be no more than
0.78 (1/1.28). Furthermore, the enhancing actions of EtOH overcome a
modest EtOH-dependent reduction in
T263I single-channel conductance
(Fig. 4). If we correct for the 19% inhibition of single-channel
conductance at 400 mM EtOH, popen in the absence of EtOH is estimated to be at most 0.63 (0.81/1.28).
In effect, ACh is a partial agonist at
T263I nAChRs, and our
single-channel kinetic data suggest that the
T263I mutation destabilizes the open-channel state relative to that of the wild-type receptor. Single-channel
T263I currents recorded at low ACh show kinetic behavior consistent with this low opening probability estimate.
Channel lifetimes for
T263I receptors are at least 20-fold shorter
than wild-type channels, demonstrating that the closing rate of
T263I receptors is much higher than that of wild-type nAChRs.
Although our concentration jumps are not fast enough to directly
estimate opening rates, currents from rapidly perfused patches
expressing
T263I nAChRs rise in under 1 ms (10-90% rise times are
0.5 ms in Fig. 1A), demonstrating that ACh binding and channel-opening
rates are not dramatically slower than those in wild-type nAChRs. Of
note, a homologous
subunit mutation,
S252I, does not confer a
T263I phenotype to nAChRs. Both the ACh EC50 and average channel lifetime for
S252I nAChRs are near those of wild
type, and EtOH does not increase maximal currents in patches expressing
S252I receptors, indicating that popen is near
1.0 (Forman, 1997
; Zhou and Forman, submitted for publication).
Finally, at least part of EtOH's effect on popen
is due to a decrease in channel closing rate (
), because apparent
channel lifetimes were significantly longer in the presence of EtOH.
This conclusion agrees with previous reports of single-channel kinetic analysis of EtOH effects in wild-type nAChRs (Aracava et al., 1991
;
Bradley et al., 1994
).
We can closely simulate EtOH's effects on
T263I receptors by
increasing
/
in as shown in Fig. 6, and this mechanism can also account for EtOH effects in wild-type nAChRs. Let us assume that
the effects of EtOH on the
T263I activation mechanism are the same
as those in wild-type receptors but adjust our model to incorporate the
higher baseline popen characterizing these channels. This situation is approximately represented by the simulated results in Fig. 6 (left panel) at a
/
ratio of 40 (
, derived from a simulation with
= 20,000 s
1 and
= 500 s
1), giving popen =
/(
+
) = 0.976 and a fitted EC50 = 12 µM. Assuming 300 mM EtOH causes a 4-fold increase in
/
to 160 (
and
, derived from simulation with
= 20,000 s
1 and
= 125 s
1),
Fig. 6 predicts that wild-type EC50 will drop
about 2-fold to 6.4 µM while popen rises to
0.994. Again, the model closely approximates experimental observations
(Forman et al., 1989
; Wu et al., 1994
). To generalize, our model
predicts that EtOH will have an equivalent effect on the
EC50 derived from macroscopic current in these
receptors, but EtOH's effect on currents at maximal agonist occupancy
will depend on the popen for the specific
agonist/receptor pair as well as the degree of EtOH channel inhibition.
We confirmed this generalization in another mutant nAChR with a low
popen,
Y198F. This mutation is in the agonist
binding domain of nAChR (Tomaselli et al., 1991
) and, like
T263I, is characterized by a low popen and high ACh
EC50. Indeed, in the presence of 300 mM EtOH, ACh
concentration responses from patches expressing
Y198F are shifted
leftward (2-fold reduction in EC50) and maximum
currents are enhanced by about 35% (data not shown). As seen with both
wild-type and
T263I nAChRs,
Y198F single-channel conductance is
also inhibited by 19 ± 2.7% in the presence of 400 mM EtOH.
We conclude that the effects of EtOH on the gating kinetics of
T263I
and
Y198F receptors are the same as those in wild-type receptors.
EtOH shifts ACh-response curves leftward by the same degree (about
2-fold at 300 mM EtOH) in wild-type and mutant nAChRs. The 2-fold
leftward shift can be quantitatively accounted for by a 4-fold increase
in
/
, but our data do not rule out a small additional direct EtOH
enhancement of agonist binding. EtOH's differential effects on mutant
and wild-type receptor currents at saturating ACh concentrations are
explained by the different microscopic opening probabilities in the
absence of EtOH. The increased popen is
associated with slowed channel closing rates, indicating a stabilized
open state, and others have suggested that EtOH may also increase
opening rates (Bradley et al., 1994
). High-resolution single-channel
burst analysis may define the relative contributions of opening and
closing rate changes to EtOH's enhancing action.
| |
Appendix: Relationship between EC50 and /
ratio in Fig. 5: A Steady-State Solution |
|---|
|
|
|---|
Because neither agonist block nor desensitization limit peak current in our measurements, peak current can be approximated using a steady-state assumption. Figure 5, modified to remove both agonist block and desenstization, predicts that the steady-state fraction of receptors open at a given agonist concentration is:
|
(A.1) |
is
defined as
/
. At saturating agonist, this fraction approaches (1 +
)
1 =
/(
+
) = popen.
At A = EC50,
nopen/ntotal = 1/2(1 +
)
1. Setting eq. A.1 equal to this
value results in the following quadratic equation:
|
(A.2) |
|
(A.3) |
1, which is the case for nAChRs with ACh as agonist,
eq. A.3 is approximated by EC50 = KA ×
= KA × (
/
)
1/2
which is the result predicted by our simulation in Fig. 6.
| |
Acknowledgments |
|---|
We thank Carol Gelb for her expert technical assistance. We are also grateful to Drs. James McLaughlin (Tufts Medical School, Boston, MA) and Cesar Labarca (California Institute of Technology, Pasadena, CA) for their generous sharing of cDNAs.
| |
Footnotes |
|---|
Received June 20, 1998; Accepted October 19, 1998
This research was supported by the Massachusetts General Hospital Department of Anesthesia and Critical Care and a grant from National Institutes of Health (1-K21-AA00206, to S.A.F.). Some of these results were reported at the 1998 Research Society of Alcoholism meeting: Alcoholism (1998) 22:46A (no. 258).
Send reprint requests to: Stuart A. Forman, Department of Anesthesia and Critical Care, CLN-3, Mass. General Hospital, Boston, MA, 02114. E-mail: forman{at}helix.mgh.harvard.edu
| |
Abbreviations |
|---|
ACh, acetylcholine; nAChR, nicotinic acetylcholine receptor; EtOH, ethanol.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. JERLHAG, M. GROTLI, K. LUTHMAN, L. SVENSSON, and J. A. ENGEL ROLE OF THE SUBUNIT COMPOSITION OF CENTRAL NICOTINIC ACETYLCHOLINE RECEPTORS FOR THE STIMULATORY AND DOPAMINE-ENHANCING EFFECTS OF ETHANOL Alcohol Alcohol., September 1, 2006; 41(5): 486 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rusch, H. Zhong, and S. A. Forman Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zuo, J. Z. Yeh, and T. Narahashi Dual Action of n-Butanol on Neuronal Nicotinic alpha 4beta 2 Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scheller and S. A. Forman Coupled and Uncoupled Gating and Desensitization Effects by Pore Domain Mutations in GABAA Receptors J. Neurosci., October 1, 2002; 22(19): 8411 - 8421. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Jankov, R. Belcastro, E. Ovcina, J. Lee, H. Massaeli, S. J. Lye, and A. K. Tanswell Thromboxane A2 Receptors Mediate Pulmonary Hypertension in 60% Oxygen-exposed Newborn Rats by a Cyclooxygenase-independent Mechanism Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 208 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dilger The effects of general anaesthetics on ligand-gated ion channels Br. J. Anaesth., July 1, 2002; 89(1): 41 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zuo, G. L. Aistrup, W. Marszalec, A. Gillespie, L. E. Chavez-Noriega, J. Z. Yeh, and T. Narahashi Dual Action of n-Alcohols on Neuronal Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2001; 60(4): 700 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Godden, R. A. Harris, and T. V. Dunwiddie Correlation between Molecular Volume and Effects of n-Alcohols on Human Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 716 - 722. [Abstract] [Full Text] |
||||
![]() |
T. Narahashi Neuroreceptors and Ion Channels as the Basis for Drug Action: Past, Present, and Future J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 1 - 26. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||